# Regulatory Compliance & Audit Guide
**FDA 21 CFR Part 11 & CDSCO Good Distribution Practices (GDP) Alignment**

---

## 1. REGULATORY CONTEXT
Pharmaceutical supply chains are legally governed by:
- **US FDA 21 CFR Part 11**: Regulations on electronic records and electronic signatures.
- **CDSCO Good Distribution Practices**: Indian national guidelines on temperature control and counterfeit drug prevention.
- **EU Guidelines on GDP (2013/C 343/01)**: Mandates temperature monitoring and audit-ready data preservation for medicinal products.

---

## 2. HOW THIS FRAMEWORK SATISFIES MANDATES

| Mandate Requirement | Traditional Centralized Failure | Framework Cryptographic Compliance |
| :--- | :--- | :--- |
| **Audit Trails (Tamper-Evident)** | Administrators can edit database logs or overwrite audit records. | On-chain append-only blockchain transactions cannot be edited, deleted, or backdated. |
| **Electronic Signatures** | Passwords or weak session cookies used to sign delivery receipts. | Asymmetric ECDSA secp256k1 digital signatures uniquely tied to authorized private keys. |
| **System Validation** | Closed, proprietary black-box database software. | Open-source, deterministic smart contracts with automated Hardhat/Pytest verification. |
| **Incident Quarantine** | Delays between incident detection, human notification, and inventory hold. | Autonomous smart contract execution sets `QUARANTINED` status in the exact same block as the breach. |
